文献速递头颈外科

头颈癌患者远程症状监测与可穿戴活动监测的可行性与可接受性:混合方法试点研究

Feasibility and Acceptability of Remote Symptom Monitoring and Wearable Activity Monitoring in Head and Neck Cancer Patients: A Mixed Methods Pilot Study.
PubMed 文献 · Head Neck · 2026-10-02

本研究纳入12例接受放化疗的头颈癌患者,评估电子患者报告结局(ePRO)与可穿戴活动监测(WAM)的可行性与可接受性。结果显示患者对ePRO和WAM监测持接受态度。

要点

  • 头颈癌放化疗患者对ePRO和WAM监测接受度高
  • ePRO可弥补传统评估对症状的低报
  • WAM提供连续监测,助临床快速响应

核心结论

  • 头颈癌放化疗患者对参与ePRO和WAM研究持接受态度。

研究设计与样本

  • 混合方法试点研究,纳入12例接受放化疗的头颈癌患者,使用ePRO和WAM进行评估。

主要发现

  • 患者对ePRO和WAM为基础的监测持接受态度。

临床怎么用

  • 可考虑在头颈癌放化疗患者中采用ePRO和WAM进行症状与毒性监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment-related symptoms and toxicities are common in Head and Neck Cancer (HNC) patients undergoing chemoradiation (CRT). This underscores the importance of timely interventions and effective symptom and toxicity monitoring strategies to mitigate complications and improve quality of life (QoL). Traditional clinician and care team assessments often underreport patient symptoms, leading to urgent care and emergency room admissions, referred to as health care utilization (HCU). In contrast, electronically captured patient-reported outcomes (ePROs) are associated with improved survival, better health-related QoL, and lower HCU. Wearable activity monitors (WAMs) offer an additional method for continuous monitoring, enabling clinicians to detect symptoms and toxicities more efficiently and respond rapidly to patient needs. METHODS: 12 HNC patients were assessed with ePROs and WAMs during CRT. RESULTS: HNC patients undergoing CRT are receptive to ePRO and WAM-based monitoring. CONCLUSIONS: HNC patients are receptive to participating in ePROs and WAM studies.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Patel KB, Geiss C, Welniak T, et al. Feasibility and Acceptability of Remote Symptom Monitoring and Wearable Activity Monitoring in Head and Neck Cancer Patients: A Mixed Methods Pilot Study. Head Neck. 2026. PMID: 42827275. doi:10.1002/hed.70491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。